Summary of Dr. O'Connor's Disclosures
Funding/Research Support
1. Current
a. Alexion, now part of AstraZeneca
b. Viela Bio, now part of Horizon
2. Past/Completed
a. Ra Pharm, now part of UCB
b. Cabaletta Bio
Consulting
1. Takeda
2. Alexion
3. Roche
4. Cabaletta
Speaking Fees and Honoraria
1. Viela Bio, now part of AstraZeneca
2. Genentech
3. Roche
4. UCB
5. New England Biolabs
Equity and/or Shareholder
1. Equity shareholder of Cabaletta Bio